These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 23474561

  • 1. Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.
    Stevenson R, Libutti SK, Saif MW.
    JOP; 2013 Mar 10; 14(2):155-7. PubMed ID: 23474561
    [Abstract] [Full Text] [Related]

  • 2. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
    Lawrence B, Gustafsson BI, Kidd M, Pavel M, Svejda B, Modlin IM.
    Endocrinol Metab Clin North Am; 2011 Mar 10; 40(1):111-34, viii. PubMed ID: 21349414
    [Abstract] [Full Text] [Related]

  • 3. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.
    Singh S, Law C.
    Expert Rev Gastroenterol Hepatol; 2012 Jun 10; 6(3):313-34. PubMed ID: 22646254
    [Abstract] [Full Text] [Related]

  • 4. Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours.
    Oberg K.
    Endocr Relat Cancer; 2011 Oct 10; 18 Suppl 1():S17-25. PubMed ID: 22005113
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biomarkers in neuroendocrine tumors.
    Duque M, Modlin IM, Gupta A, Saif MW.
    JOP; 2013 Jul 10; 14(4):372-6. PubMed ID: 23846930
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
    Modlin IM, Kidd M, Bodei L, Drozdov I, Aslanian H.
    Am J Gastroenterol; 2015 Aug 10; 110(8):1223-32. PubMed ID: 26032155
    [Abstract] [Full Text] [Related]

  • 14. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L, Chen M, Chen J.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar 25; 20(3):357-360. PubMed ID: 28338171
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: current data and clinical outlook.
    Mateo J, Heymach JV, Zurita AJ.
    Mol Diagn Ther; 2012 Jun 01; 16(3):151-61. PubMed ID: 22515658
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Angiopoietin-2 promotes disease progression of neuroendocrine tumors.
    Detjen KM, Rieke S, Deters A, Schulz P, Rexin A, Vollmer S, Hauff P, Wiedenmann B, Pavel M, Scholz A.
    Clin Cancer Res; 2010 Jan 15; 16(2):420-9. PubMed ID: 20068079
    [Abstract] [Full Text] [Related]

  • 20. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.
    Belli SH, Oneto A, Aranda C, O'Connor JM, Domenichini E, Roca E, Méndez G, Bestani MC, Parma P, Giacomi N, Marmissolle F.
    Acta Gastroenterol Latinoam; 2009 Sep 15; 39(3):184-9. PubMed ID: 19845257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.